市场快照

Study Period: | 2018 - 2026 |
CAGR: | 9.3 % |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and it's growth?
市场概况
在预测期内,中国药物输送设备市场预计将录得 9.3% 的复合年增长率。推动中国给药装置市场增长的主要因素是慢性病负担的增加、益处和便利性,导致对自我注射器的需求增加,以及生物市场的增长,导致对给药装置的需求增加. 慢性病的日益流行导致药物输送装置的使用增加,特别是一次性注射器。许多慢性病导致的死亡可能与癌症、心脏病、超重和糖尿病有关。
根据中华人民共和国国务院新闻办公室的数据,每年医生诊断出2.6亿人患有慢性病。慢性病每年占中国死亡人数的 85%。导致大多数死亡的疾病是癌症(27.79%)、脑血管疾病(20.22%)和心脏病(21.3%)。预计这将影响市场,人口增长是影响市场的因素之一,因为人口增长被认为是该国最重要的因素。帮助药物输送设备市场增长的另一个因素是技术的不断进步,这可能是预测期内推动市场增长的关键因素之一。
Scope of the report
Drug delivery systems are the medical equipment and devices used to deliver the medicines to human bodies and different systems. These are specifically designed to administer the specific drugs in accordance with the different techniques of administration. Such tools are used for therapeutic procedures and the whole process of healing.
By Device Type | ||||||||
| ||||||||
Implantable | ||||||||
| ||||||||
Other Dvice Types |
By Therapeutic Application | |
Cardiovascular | |
Oncoloy | |
Autoimmune Disorder | |
Pulmonary Disease | |
Other Therapeutic Applications |
By Sales Channel | |
Hospitals | |
Pharmacy | |
Other Sales Channels |
主要市场趋势
自注射给药装置板块有望在中国给药装置市场占有重要份额
自注射设备的创新和发展无止境,推动了该国市场的增长。与自注射注射剂相关的其他主要优点是发现它们使用方便且成本低。这些是适应性最强的设备,具有高精度的药物输送,并且易于使用。除此之外,随着自注射设备的创新,这些产品的接受度在过去几年中有所增加。尽管如此,自注射剂的优势和提高自我管理意识可能有助于推动预测期内的整体市场增长。

To understand key trends, Download Sample Report
竞争格局
中国药物输送设备市场竞争激烈,由多个参与者组成。就市场份额而言,目前主导市场的主要企业寥寥无几,一些知名企业正在大力与其他公司进行收购和合资,以巩固其在该国的市场地位。目前主导市场的一些公司是 Gerresheimer AG、辉瑞公司、F. Hoffmann-La Roche AG、Becton、Dickinson and Company 和 Teva Pharmaceutical Industries Ltd.。
主要玩家
Gerresheimer AG
Pfizer Inc.
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
Teva Pharmaceutical Industries Ltd.
*Disclaimer: Major Players sorted in no particular order

Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increased Prevalence of Chronic Diseases
-
4.2.2 Advancement in Technology
-
-
4.3 Market Restraints
-
4.3.1 The High Cost of Development
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Device Type
-
5.1.1 Nasal
-
5.1.1.1 Inhalers
-
5.1.1.2 Other Device Types
-
-
5.1.2 Implantable
-
5.1.3 Injectable
-
5.1.3.1 Conventional Drug Delivery Devices
-
5.1.3.2 Self-injectable Drug Delivery Devices
-
5.1.3.2.1 Prefilled Syringes
-
5.1.3.2.2 Auto Injectors
-
5.1.3.2.3 Other Self-injectable Drug Delivery Devices
-
-
-
5.1.4 Other Dvice Types
-
-
5.2 By Therapeutic Application
-
5.2.1 Cardiovascular
-
5.2.2 Oncoloy
-
5.2.3 Autoimmune Disorder
-
5.2.4 Pulmonary Disease
-
5.2.5 Other Therapeutic Applications
-
-
5.3 By Sales Channel
-
5.3.1 Hospitals
-
5.3.2 Pharmacy
-
5.3.3 Other Sales Channels
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Gerresheimer AG
-
6.1.2 Pfizer Inc.
-
6.1.3 F. Hoffmann-La Roche AG
-
6.1.4 Becton, Dickinson and Company
-
6.1.5 Teva Pharmaceutical Industries Ltd
-
6.1.6 Merck & Co. Inc.
-
6.1.7 Novartis International AG
-
6.1.8 Sanofi SA
-
6.1.9 GlaxoSmithKline PLC
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Frequently Asked Questions
这个市场的研究期是多久?
研究了 2018 - 2028 年的中国药物输送设备市场。
中国给药器械市场增速如何?
未来 5 年,中国给药器械市场将以 9.3% 的复合年增长率增长。
谁是中国药物输送设备市场的主要参与者?
F. Hoffmann-La Roche AG、Becton、Dickinson and Company、Gerresheimer AG、Pfizer Inc.、Teva Pharmaceutical Industries Ltd 是在中国给药设备市场运营的主要公司。